Home › B-Cell Lymphoma › Washington › Seattle
B-Cell Lymphoma clinical trials in Seattle, WA
7 studies for B-Cell Lymphoma are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RecruitingPhase 1
- Swedish Cancer Institute (SCI), Seattle
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
RecruitingPhase 1/2
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
RecruitingPhase 1
- Fred Hutch Cancer Center, Seattle
DALY II USA/ MB-CART2019.1 for DLBCL
RecruitingPhase 2
- Fred Hutchinson Cancer Center, Seattle
Epcoritamab With Dose Adjusted Etoposide, Cyclophosphamide, Vincristine, Doxorubicin, Prednisone and Rituximab (EPOCH-R) for the Treatment of Aggressive B-Cell Non-Hodgkin Lymphoma
RecruitingPhase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
BAFFR-targeting CAR T Cells for Patients With Relapsed or Refractory B-NHL
RecruitingPhase 1
- Providence Swedish Cancer Institute, Seattle
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
RecruitingPhase 1
- Seattle Children's Hospital, Seattle
B-Cell Lymphoma trials in other cities
- New York City, NY19 studies
- Houston, TX16 studies
- Chicago, IL12 studies
- Nashville, TN11 studies
- Philadelphia, PA11 studies
- Rochester, MN10 studies
- Milwaukee, WI9 studies
- Baldwin Park, CA9 studies
- Cleveland, OH9 studies
- Salt Lake City, UT8 studies
- Boston, MA8 studies
- Pittsburgh, PA7 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer53 studies
- Cancer (all types)49 studies
- Prostate Cancer42 studies
- Acute Myeloid Leukemia40 studies
- Breast Cancer39 studies
- Metastatic Cancer39 studies
- Colorectal Cancer34 studies
- Lung Cancer33 studies
- Ovarian Cancer30 studies
- Multiple Myeloma22 studies
- Myelodysplastic Syndromes21 studies
- Acute Lymphoblastic Leukemia21 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.